Cellebrite DI Ltd. (CLBT)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-05-14

Key Insights

  • President of Products & Technology acquired 423,550 ordinary shares through RSU vesting with staggered schedule: 105,898 shares vesting May 4, 2027, then 26,471 shares quarterly through May 4, 2030, indicating multi-year equity retention program.
  • RSU award at $0 price represents compensation arrangement rather than open market purchase, suggesting this is part of executive incentive structure rather than insider confidence signal through direct buying.
  • Officer's base equity stake post-transaction is 423,550 shares held directly, establishing significant personal financial alignment with company performance over the next 4-year vesting period.
Filing tone (AI): Neutral
View Original Filing →
Insider Trading Filed: 2026-05-14

Key Insights

  • Global Chief Revenue Officer Marcus Jewell sold 383 ordinary shares on May 12, 2026, at a weighted average price of $13.01, reducing his direct beneficial ownership to 452,759 shares.
  • The sale was driven by tax obligations from RSU vesting (granted February 11, 2025) rather than a loss of confidence in the company, as shares were sold across a narrow price range ($12.84-$13.175) indicating a systematic tax-driven transaction.
  • The CRO maintained substantial shareholdings of 452,759 shares post-transaction, suggesting continued confidence in Cellebrite's future despite the equity reduction for tax purposes.
Filing tone (AI): Neutral
View Original Filing →
Insider Trading Filed: 2026-05-14

Key Insights

  • Chief Marketing Officer David Gee sold 228 ordinary shares on May 12, 2026, at a weighted average price of $13.01, reducing his beneficial ownership to 147,705 shares.
  • The share disposition was driven by tax obligations from the vesting of RSUs granted on February 11, 2025, indicating this was a forced sale for tax compliance rather than a loss of confidence in the company.
  • The shares were sold across multiple transactions within a narrow price range ($12.84-$13.175), suggesting orderly execution consistent with pre-planned tax withholding arrangements rather than urgent liquidation.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new Cellebrite DI Ltd. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.